Solving The Challenge Of Comparator Drug Procurement

A leading pharmaceutical company approached Fisher Clinical Services to assist them with obtaining comparator study medication for a global Phase III program. The trial was focused on an infectious disease and would involve 25 countries across 130 investigator sites.

In a previous program, the Sponsor had sourced comparator medication directly from the manufacturer, but as all sourcing was done via a central office the price for the study medication in Europe was expensive.